Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 8, 2006, Pages 1799-1805

  Yasmin, ^a   McEniery, Carmel M ^a   O'Shaughnessy, Kevin M ^a   Harnett, Patrick ^a   Arshad, Asif ^a   Wallace, Sharon ^a   Maki Petaja, Kaisa ^a   McDonnell, Barry ^b   Ashby, Mike J ^a   Brown, John ^c   Cockcroft, John R ^b   Wilkinson, Ian B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c TRINITY COLLEGE   (United Kingdom)

Author keywords

Aortic pulse wave velocity; Augmentation index; MMP 9 gene polymorphisms; MMP 9 levels; Serum elastase activity

Indexed keywords

BIOLOGICAL MARKER; ELASTASE; GELATINASE B; GENOMIC DNA; ARGININE; GLUTAMINE; PANCREATIC ELASTASE;

ADULT; AGED; ALLELE; ARTERY MUSCLE; ARTICLE; BLOOD PRESSURE; DEFENSE MECHANISM; DNA POLYMORPHISM; ENZYME ACTIVITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MUSCLE RIGIDITY; PRIORITY JOURNAL; PULSE WAVE; SUPINE POSITION; ARTERY; BLOOD; BLOOD FLOW VELOCITY; COHORT ANALYSIS; ELASTICITY; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; MIDDLE AGED; PATHOPHYSIOLOGY; PULSE RATE; REFERENCE VALUE; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARGININE; ARTERIES; BLOOD FLOW VELOCITY; COHORT STUDIES; ELASTICITY; GLUTAMINE; HETEROZYGOTE; HUMANS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PANCREATIC ELASTASE; POLYMORPHISM, GENETIC; PULSE; REFERENCE VALUES; REGRESSION ANALYSIS; VARIATION (GENETICS);

EID: 33746814986     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000227717.46157.32     Document Type: Article

References (34)

1. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. London: Arnold; 1998.
2. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic basis of arterial stiffness. Hypertension. 2005;45:1050-1055.
3. Bizbiz L, Bonithon-Kopp C, Ducimetiere P, Berr C, Alperovitch A, Robert L, the EVA group. Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA study. Atherosclerosis. 1996;120:47-55.
4. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L; AtheroGene Investigators. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003;107:1579-1585.
5. Yasmin, McEniery CM, Wallace S, Dhakam Z, Pusalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, Wilkinson IB. Matrix metalloproteinases-9 and 2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb and Vasc Biol. 2005;25:372-378.
6. Zhang B, Henney A, Eriksson P, Haamsten A, Watkins, Shu Y. Genetic variation at the matrix metalloproteinase-9 locus on chromososme 20q12.2-13.1. Hum Genet. 1999;105:418-423.
7. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999;99:1788-1794.
8. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. Matrix metalloproteinase-9 influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol. 2004;24:1479-1484.
9. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb and Vasc Biol. 2004;24:969-974.
10. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; On behalf of the Anglo-Cardiff Collaboration Trial (ACCT) Investigators. Normal vascular ageing: differential effects on wave reflection and aortic pulse wave velocity. The Anglo-Cardiff Collaborative Trial (ACCT 1). J Am Coll Cardiol. 2005;46:1753-1760.
11. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monitoring. 1996;1:55-61.
12. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993;14:160-167.
13. Segers P, Qasem A, DeBacker T, Carlier S, Verdonck P, Avolio A. Peripheral "oscillatory" compliance is associated with aortic augmentation index. Hypertension. 2001;37:1434-1439.
14. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932-937.
15. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ. The reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998;16:2079-2084.
16. Safar ME, London GM. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. The clinical committee of arterial structure and function. Working group on vascular structure and function of the European Society of Hypertension. J Hypertens. 2000;18:1527-1535.
17. Lahiri DK, Nurmberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl Acids Res. 1991;19:5444.
18. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995;2:311-322.
19. Ardlie KG, Kruglyak L, Seielstad M. Patterns of linkage disequilibrium in the human genome. Nature Reviews: Genetics. 2002;3:299-309.
20. Almasy L, MacCluer JW. Association studies of vascular phenotypes. How and Why? Arterioscler Thromb Vasc Biol. 2002;22:1055-1057.
21. Morgan AR, Zhang B, Tapper W, Collins A, Ye S. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med. 2003;81:321-326.
22. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
23. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434-2439.
24. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001;21:2046-2050.
25. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106:2085-2090.
26. Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, Grogan T, Marquez LA, Janowska-Wieczorek A. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in non-Hodgkin's lymphomas. Blood. 1999;94:2020-2089.
27. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr. 1997;7:159-178.
28. Sho E, Sho M, Singh TM, Nanjo H, Komatsu M, Xu C, Masuda H, Zarins CK. Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. Exp Mol Pathol. 2002;73:142-153.
29. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension. 2002;39:197-202.
30. Nikkari ST, Hoyhtya M, Isola J, Nikkari T. Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol. 1996;149:1427-1433.
31. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, Nakamura T, Yamashita S, Matsuzawa Y. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003;108:1469-1473.
32. Takeshita S, Tokutomi T, Kawase H, Nakatani H, Tsujimoto H, Kawamura Y, Sekine I. Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol. 2001;125:340-344.
33. Judson R, Stephens JC, Windemuth A. The predictive power of haplotypes in clinical response. Pharmacogenomics. 2000;1:15-26.
34. Chapman JM, Cooper JD, Todd JA, Clayton DG. Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered. 2003;56:18-31.